Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OMEGA-3 FATTY ACIDS AS FIRST-LINE TREATMENT IN PAEDIATRIC DEPRESSION. A Phase III, 36-week, Multi-centre, Double-blind, Placebo-controlled Randomized Superiority Study

NCT03167307 is registered in ClinicalTrials.gov with Gregor Berger as lead sponsor.

NCT NCT03167307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03167307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OMEGA-3 FATTY ACIDS AS FIRST-LINE TREATMENT IN PAEDIATRIC DEPRESSION. A Phase III, 36-week, Multi-centre, Double-blind, Placebo-controlled Randomized Superiority Study
Lead sponsor
Gregor Berger
Phase
Phase 3
Overall status
Completed
Start date
April 28, 2017
Completion date
March 24, 2022
Enrollment
257 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

depression